Detecting oral abnormalities early leads to more treatment options, potentially less invasive or radical treatments and better patient outcomes. Oral cancer incidence rates have increased every year over the last several years in the United States and it continues to rise today. The traditional obvious risk factors for oral cancer include tobacco (smokeless and smoked) and excessive alcohol consumption. Consuming both alcohol and tobacco at the same time results in a synergistic effect, increasing the risk for oral cancer by 30-fold. The newest risk factor for oral cancer is the human papillomavirus (HPV). HPV is the fastest-growing risk factor and results in younger patients being diagnosed with oral cancer.
Regardless of the cause of oral cancer, early discovery has been proven to save lives. The survival rates for cancers are much higher if the cancer is discovered in its early stages. The same is true for oral cancer. If oral cancer is found early, patients have an 80%-90% survival rate, while late discovery results in a survival rate of 34%-50%. Because of these facts, DiNinno Family Dental is committed to annual cancer screenings. Once a year, we will perform a dedicated screening consisting of a visual examination, a digital examination and a Velscope examination.
Introducing the VELscope® Vx Enhanced Oral Assessment System, which centers on a wireless, handheld scope that uses natural tissue fluorescence visualization to help discover oral mucosal abnormalities that might otherwise have been overlooked.
Cleared by the FDA, and approved by Health Canada, and the World Health Organization, the award-winning VELscope® Vx is the world’s most widely used adjunctive device for the discovery of:
- Viral, fungal and bacterial infections;
- Inflammation from a variety of causes (lichen planus and lichenoid reactions, allergy to amalgam fillings, etc.);
- Squamous papillomas;
- Salivary gland tumors;
- Cancer and pre-cancer;
- Other oral mucosal conditions…
Contact DiNinno Family Dental for more information about VELscope.